Publications & Blog
Synthetic Data in Drug Development - What it is and How it Relates to AI-informed Approaches
In drug development, researchers are investigating the viability of synthetic data as an alternative to RWD in some of its AI-informed approaches. Let’s take a closer look at how the use of synthetic data is impacting the drug development landscape.
Synthetic Data in Drug Development - What it is and How it Relates to AI-informed Approaches
In drug development, researchers are investigating the viability of synthetic data as an alternative to RWD in some of its AI-informed approaches. Let’s take a closer look at how the use of synthetic data is impacting the drug development landscape.
How to Invest in AI to Improve Clinical Trials
In this blog, we take a look at some specific ways current and emerging AI technologies are poised to improve clinical trials – from processes to patient outcomes – and what to look for when choosing an AI partner or platform.
How to Invest in AI to Improve Clinical Trials
In this blog, we take a look at some specific ways current and emerging AI technologies are poised to improve clinical trials – from processes to patient outcomes – and what to look for when choosing an AI partner or platform.
%20(1).png)
Generative AI & Drug Development – What You Need To Know
Researchers are beginning to look at the utility of generative AI in drug development for specific ways this particular type of machine learning technology might help streamline, improve, or otherwise accelerate the development of new drugs. Here’s what you need to know about generative AI and drug development.
Generative AI & Drug Development – What You Need To Know
Researchers are beginning to look at the utility of generative AI in drug development for specific ways this particular type of machine learning technology might help streamline, improve, or otherwise accelerate the development of new drugs. Here’s what you need to know about generative AI and drug development.
Integrating AI/ML Models for Patient Stratification Leveraging Omics Dataset and Clinical Biomarkers from COVID-19 Patients
In this manuscript, we demonstrate the recent advances and predictive accuracies in AI- and ML-based patient stratification modeling linking omics and clinical biomarker datasets, focusing on COVID-19 patients.
Integrating AI/ML Models for Patient Stratification Leveraging Omics Dataset and Clinical Biomarkers from COVID-19 Patients
In this manuscript, we demonstrate the recent advances and predictive accuracies in AI- and ML-based patient stratification modeling linking omics and clinical biomarker datasets, focusing on COVID-19 patients.
.svg)
